John Hancock Multifactor Health Care
ALTAR
Score™
6.9% info Recommen-
dation
OVERWEIGHT
2019E    2020E
P/E
ratio
17.5x P/Sales
ratio
1.1x
P/BV
ratio
3.3x Div.
yield
1.3%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
The John Hancock Multifactor Health Care ETF tracks an index of US health care stocks, weighted for exposure to 4 factors: small size, low relative price, high profitability and high momentum.

FUND BASICS
Category US Equities
Fund Sponsor John Hancock
Website etf.jhinvestments.com
Inception date Sep 29, 2015
Assets (mns) $51
Currency USD
Expense ratio 40 bp
Distributions Semi-Annually

FUND STRUCTURE
Regulation Open-End Investment Company
Custodian
Weighting Multi-Factor
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 114
Wgt avg mkt cap (mns) $96,409
Large cap (>$10bn) 86.3%
Mid cap ($2-10bn) 13.5%
Small cap (<$2bn) 0.2%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
JOHNSON & JOHNSON 5.9 %
UNITEDHEALTH GROUP INC 5.3 %
PFIZER INC 4.4 %
MERCK & CO. INC. 4.2 %
MEDTRONIC PLC 2.5 %
ABBOTT LABORATORIES 2.4 %
AMGEN INC 2.3 %
THERMO FISHER SCIENTIFIC INC 2.2 %
CIGNA CORP 2.1 %
GILEAD SCIENCES INC 2.1 %
Total 33.4 %

TOP COUNTRY EXPOSURE
UNITED STATES 93.2 %
IRELAND 5.3 %
BRITAIN 0.9 %








HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru October 31)
Year-to-date 1 year 5 years 10 years Since Incep.
11.2% 6.1% -- -- 9.9%

Market Correlations
versus... Beta R-squared
S&P500 0.94 69%
MSCI EAFE 0.80 43%
MSCI Emg. Mkts. 0.60 39%

Technical Indicators
Recent close $34.99
30d moving avg. $33.78
Annualized volatility 13.6%
Short interest (ETF) 0.0%
Short interest (Underlying) 2.9%
Relative strength (RSI) 73

Liquidity measures
Avg. volume (thou.) 4
Turnover 0.3%
Bid/Ask (% of price) 0.15%
ADV underlying (mns) $21,220

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the John Hancock Multifactor Health Care ETF based on the alternatives' overlap in portfolio holdings with JHMH. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: JHMH Expense: 40 bp ALTAR Score™: 6.9%


ALTERNATIVE ETFs BASED ON OVERLAP WITH JHMH
Ticker Fund
Name
Overlap1
vs JHMH
(%)
Expense
ratio
(bp)
Savings
vs JHMH
(bp)
ALTAR
Score™
(%)
ALTAR
vs JHMH
(%)
FHLC Fidelity MSCI Health Care 77.3 8 32 6.1 -0.8
IYH iShares US Healthcare 77.3 43 -3 6.6 -0.4
VHT Vanguard Health Care 76.9 10 30 6.1 -0.9
XLV Health Care Select Sector SPDR 72.7 13 27 7.5 +0.6
RYH Invesco S&P Equal Weight Healthcare 68.4 40 0 7.3 +0.4
IXJ iShares S&P Global Healthcare 63.7 46 -6 6.6 -0.4
FXH First Trust Health Care Alphadex 55.4 63 -23 7.4 +0.4
IEHS iShares Evolved U.S. Healthcare Staples 53.9 18 22 6.1 -0.8
IEIH iShares Evolved U.S. Innovative Healthcare 42.7 18 22 4.9 -2.1
PJP Invesco Dynamic Pharmaceuticals 33.5 56 -16 10.0 +3.1
GDNA Goldman Sachs Motif Human Evolution 29.1 50 -10 1.0 -5.9
LNGR Global X Longevity Thematic 26.9 50 -10 3.7 -3.2
FTXH First Trust Nasdaq Pharmaceuticals 25.3 60 -20 5.6 -1.3
PPH VanEck Vectors Pharmaceuticals 24.3 36 4 9.6 +2.6
IHI iShares DJ US Medical Devices 24.2 43 -3 3.9 -3.1
HLAL Wahed FTSE USA Shariah 23.1 50 -10 5.7 -1.2
HTEC Robo Global Healthcare Technology and Innovation 23.0 68 -28 0.0 -6.9
IHE iShares DJ US Pharmaceuticals 22.8 42 -2 5.6 -1.4
XHS SPDR S&P Health Care Services 22.6 35 5 6.5 -0.4
XHE SPDR S&P Health Care Equipment 22.2 35 5 2.2 -4.7

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
John Hancock Multifactor Health Care
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

OVERWEIGHT

Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 21.2 %
Divided by: Fwd. P/BV 2.9 x
Less: Expense ratio 40 bp
Equals: ALTAR Score 6.9 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.44 CATEGORY
AVERAGE
1.55
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.